z-logo
Premium
Determination of Tripamide in human urine by high‐performance liquid chromatography and high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry
Author(s) -
Kim Yunje,
Hwang Joungboon,
Kim Myungsoo,
Lee Won
Publication year - 2003
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.913
Subject(s) - chemistry , chromatography , high performance liquid chromatography , mass spectrometry , electrospray ionization , tandem mass spectrometry , liquid chromatography–mass spectrometry , chromatography detector , direct electron ionization liquid chromatography–mass spectrometry interface , urine , electrospray , chemical ionization , ionization , organic chemistry , biochemistry , ion
Tripamide is a drug widely used in clinical practice for the treatment of hypertension and edema. This work evaluated a screening method for Tripamide and its urinary metabolites in human urine, using high‐performance liquid chromatography diode‐array detection (HPLC/DAD). Identification of these metabolites was investigated by high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI‐MS/MS) after dosing with 15 mg Tripamide. Acid hydrolysis showed that Tripamide is conjugated in the body. Two suspected metabolites were detected by HPLC/DAD. HPLC/ESI‐MS/MS analysis suggested that these metabolites were probably hydroxylated together with loss of the ‐NH 2 group and dehydrogenation. These results will be useful in confirmation methods for Tripamide in doping control. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom